Microfluidic Devices and Systems: A Two-Part Webinar Series

Dates: Session 1, Tuesday, January 14, 2020
Session 2, Tuesday, January 21, 2020

Duration: 60 minutes, Each Session

Time: 11AM Central Standard Time

 What Does it Cover?

30 years after the introduction of the concept of the “miniaturized total chemical analysis system (µTAS)” and about 20 years after the gold digger`s frenzy about how this technology would revolutionize all aspects of chemical, biological or diagnostic applications, it is worth to have a look how this technology has matured (or at what places it might have made a wrong turn). This two-stage course will provide a broad overview of all aspects of microfluidic devices and systems as an enabling technology for new product development in diagnostics and the life sciences.

Session 1 will provide an introduction into the field. Emphasis is put on the complete development process for commercial microfluidics-enabled products, covering aspects of development strategies and manufacturing aspects.

Session 2 focuses on application cases, markets as well as aspects of commercialization. Recent product examples will be presented as well as lessons learned during all stages of the development and commercialization process of microfluidics-enabled devices.

 What Will You Learn?

  • The role of microfluidics technology in the development of new products.
  • Development and modularization strategies in product development.
  • Microfabrication methods for low and high-volume production.
  • Economic aspects in the development and manufacturing of Lab-on-a-chip devices and systems.
  • Case studies of successful and unsuccessful microfluidic product introductions.
  • The current state of the markets and obstacles in the commercialization process.

 Who Should Attend?

  • Diagnostic Test Manufacturers
  • IVD Test Developers
  • Diagnostic Test End Users


Speaker Bio
Dr. Holger Becker
Co-founder and CSO of microfluidic ChipShop GmbH
Dr Holger Becker is co-founder and CSO of microfluidic ChipShop GmbH. He obtained physics degrees from the University of Western Australia/Perth (1990) and the University of Heidelberg (1991). He started to work on miniaturized systems for chemical analysis during his PhD thesis at Heidelberg University, where he obtained his PhD in Applied Physics in 1995. Between 1995 and 1997 he was a Research Associate at Imperial College with Prof. Andreas Manz. In 1998 he joined Jenoptik Mikrotechnik GmbH. Since then, he founded and led several companies in the field of microsystem technologies in medicine and the life sciences, for which he received various awards, most notably a nomination for the “Deutscher Gründerpreis” in 2004. He led the Industry Group of the German Physical Society between 2004 and 2009 and is the current chair of the SPIE ‘‘Microfluidics, BioMEMS and Medical Microsystems’’ conference, co-chair of MicroTAS 2013 and in the Industry Committee for MicroTAS since 2016. He serves on the Advisory Boards of the “Next Generation Diagnostics” and “Molecular Diagnostics Europe” conferences from Cambridge Healthtech, and of “Lab-on-a-Chip”, the Editorial Boards of “Microelectronic Engineering” and “Micro and Nanosystems” as well as on the Board of Trustees of the “Physik Journal”. In 2014, he was appointed a Fellow of The Royal Society of Chemistry (London) and in 2017 has been awarded the “Ehrennadel” of the German Physical Society. He has published more than 160 journal and conference papers with currently >6,000 citations.